Field Trial Validation of the Efficacy and Acceptability of Firocoxib, a Highly Selective Cox-2 Inhibitor, in a Group of 96 Lame Horses
To access this article, please choose from the options below
PII: S0737-0806(10)00176-0
doi:10.1016/j.jevs.2010.03.011
© 2010 Elsevier Inc. All rights reserved.
